ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag policy vaccine art neuroscience

Genome Investigator Craig Venter Reflects On Turbulent Past And Future Ambitions
Karen Young Kreeger | Jul 23, 1995 | 8 min read
And Future Ambitions Editor's Note: For the past four years, former National Institutes of Health researcher J. Craig Venter has been a major figure in the turbulent debates and scientific discoveries surrounding the study of genes and genomes. Events heated up in 1991, when NIH attempted to patent gene fragments, which were isolated using Venter's expressed sequence tag (EST)/complementary DNA (cDNA) approach for discovering human genes (M.A. Adams et al., Science, 252:1651-6, 1991). NIH's mo
Scientific Enterprise At Critical Juncture, Say Panelists, Researchers
Steven Benowitz | Oct 13, 1996 | 10+ min read
MISCONDUCT POLICY: University of Illinois' C.K. Gunsalus cites problems of oversight in academia. Is science in crisis? Scientists, historians, administrators, and others have debated this issue over the last few decades. The controversial topic was the impetus for a September 19 conference at George Washington University (GWU). Panelists at the day-long symposium, titled "Science in Crisis at the Millennium," think something has gone awry. Keith Yamamoto, University of California, San Franc
Those We Lost in 2018
Ashley Yeager | Dec 26, 2018 | 10+ min read
The scientific community said goodbye to a number of leading researchers this year.
Marching for Science, from Berlin to Sydney
Diana Kwon | Feb 19, 2017 | 5 min read
Satellite marches across the globe aim to stand in solidarity with US scientists and highlight issues in their home countries. 
AIDS Investigators Cautiously Applauding Recent Advances
Steven Benowitz | Sep 29, 1996 | 10+ min read
Discoveries announced at conference leave scientists feeling optimistic; yet their enthusiasm is tempered by several persistent concerns. AIDS researchers have many reasons to be encouraged. Studies show that treatments combining new and old drugs can control HIV levels in the blood. Moreover, many scientists and activists note, prevention efforts have helped reduce HIV infection rates. Yet the enthusiasm is tempered by several caveats. Drugs are expensive and have harsh side effects, leading
The Four R's
Amy Norton | Nov 21, 2004 | 7 min read
Teams at each of New York City's leading universities are making important research advances.
Observers Praise AIDS Report But Foresee Problems In Implementation
Steven Benowitz | May 12, 1996 | 10 min read
Problems In Implementation LOUD AND CLEAR: Attorney Lynda Dee stresses the need for communication among the institutes. When a federally appointed panel announced in March the results of its 15-month-long review of the United States government's AIDS research program, AIDS activists as well as scientists cheered. The National Institutes of Health's AIDS Research Program Evaluation Working Group's recommendations largely called for scrapping what the group saw as outdated and ineffective polic
Changes At Pew Charitable Trusts: Good News For Scientists?
Jim Detjen | Sep 18, 1988 | 5 min read
Scientists have taken over at the Pew Charitable Trusts. A year and a half ago, Thomas Langfltt, a former University of Pennsylvania neurosurgeon assumed the presidency, replacing Robert I. Smith, whose background was in accounting. Now, Rebecca Rimel, a former nurse and medical school faculty member, has been promoted to the post of executive director. She succeeds Fred Billups, a former oil company executive who had filled Pew's second highest post for 12 years. Is this good news for scientist
Mail
The Scientist Staff | Dec 1, 2007 | 6 min read
To frame, or not to frame? Re: "The future of public engagement,"1 the first thing scientists need to do is abandon all talk of tentativeness, paradigms, and social construct when talking to the public about science. This model of science is appropriate in certain circles, but I see not a shred of evidence that it has improved public scientific literacy, and [I see] a great deal of evidence that it has been used by charlatans to dismiss scientific findings or push bogus alternativ
Notebook
The Scientist Staff | Jul 7, 1996 | 7 min read
On June 14, a House Appropriations subcommittee gave some researchers cause for celebration when it surprisingly voted to remove a provision in a government spending bill that extended a ban on federal funding of human embryo research. However, their glee was short-lived. The full panel turned around on June 25 and adopted an amendment to continue the research ban. John Eppig, senior staff scientist at Jackson Laboratory in Bar Harbor, Maine, doubts that the ban will be overturned anytime soon,

Run a Search

ADVERTISEMENT